Mepindolol sulfate

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

Immunogen Synthetic peptide directed towards the N terminal region of human STIP1 Application Anti-STIP1 (AB1) antibody produced in rabbit can be used to tag stress-induced-phosphoprotein 1 (Hsp70/Hsp90-organizing protein) for detection and

InformationAPD-597 (JNJ-38431055) is a potent and selectiveG protein-coupled receptor 119 (GPR119)agonist with EC50 of 46 nM for hGPR119 and an inhibitor ofCytochrome P450 2C9 (CYP2C9)with IC50 of 5.8 μM. APD-597 (JNJ-38431055) is developed for

Selective MC3receptor agonist.

Selective MC3receptor agonist.

Selective MC3receptor agonist.

Peptide Sequence: rat Cav-3 amino acids 19-41 (CKEIDLVNRDPKNINEDIVKVDF) To be used in conjunction with Cayman&rsquos caveolin 1/3 polyclonal antibody (Catalog No. 100830) to block protein-antibody complex formation during analysis for Cav-1 or -3.

Application Dodecylethyldimethylammonium bromide (C 12 EDMAB) can be used: As a growth-directing surfactant in the synthesis of monodisperse gold nanorods. As a surfactant in the synthesis of poly(methyl methacrylate)-poly( N -isopropylacrylamide)

Application Dodecylethyldimethylammonium bromide (C 12 EDMAB) can be used: As a growth-directing surfactant in the synthesis of monodisperse gold nanorods. As a surfactant in the synthesis of poly(methyl methacrylate)-poly( N -isopropylacrylamide)

Human PD-L1 inhibitor V TFA, a human PD-1 protein binding peptide with a K d value of 3.32 μM. Human PD-L1 inhibitor V TFA inhibit the interaction of hPD-1/hPD-L1.Appearance:SolidIn Vitro:Human PD-L1 inhibitor V (Ar5M_2) is a peptide designed with

Imirestat (AL 1576) is an aldose reductase inhibitor, used for the treatment of diabetes.In VivoImirestat (1 mg/kg) improves nerve conduction velocity but is without effect upon the resistance to hypoxic conduction blockade or the deficit in

Immunotag™ Neuregulin-3 Polyclonal Antibody-HRP*